Safety and immune cell kinetics after donor natural killer cell infusion following haploidentical stem cell transplantation in children with recurrent neuroblastoma.

Young Bae ChoiMeong Hi SonHee Won ChoYoungeun MaJi Won LeeEun-Suk KangKeon Hee YooJung Hyun HerOkjae LimMiyoung JungYu Kyeong HwangKi Woong SungHong Hoe Koo

Published in: PloS one (2019)

NKI following haplo-SCT was relatively safe and feasible in patients with recurrent neuroblastoma. Further studies to enhance the graft-versus-tumor effect without increasing GVHD are needed.

Keyphrases

stem cell transplantation
high dose
low dose
single cell
young adults
cell therapy
stem cells
case control
bone marrow
acute myeloid leukemia
nk cells